Skip to main content

Table 1 Demographic and clinical characteristics of trial participants

From: Psychological therapy for mood instability within bipolar spectrum disorder: a randomised, controlled feasibility trial of a dialectical behaviour therapy-informed approach (the ThrIVe-B programme)

 

ThrIVe-B (n = 22)

Treatment as usual (n = 21)

Total (N = 43)

Gender; n (%)

 Female

14 (64)

9 (43)

23 (53)

 Male

8 (36)

12 (57)

20 (47)

Age in years

   

 Mean (SD)

43.6 (13.0)

49.3 (14.5)

46.4 (13.9)

 Median [min, max]

43 [20, 68]

51 [24, 75]

44 [20, 75]

Ethnic group; n (%)

 White

22 (100)

20 (95)

42 (98)

 Asian

0 (0)

1 (5)

1 (2)

Prescribed medication for

 Bipolar disorder; n (%)

19 (86)

19 (90)

38 (88)

 Mood stabiliser

14 (63)

12 (57)

26 (61)

 Antipsychotic

10 (46)

14 (67)

24 (56)

 Antidepressant

7 (32)

8 (38)

15 (35)

Site; n (%)

 Devon

17 (77)

17 (81)

34 (79)

 Cumbria

5 (23)

4 (19)

9 (21)

In ongoing secondary care; n (%)

 Yes

2 (9)

4 (19)

6 (14)

 No

20 (91)

17 (81)

37 (86)

Age of depression onseta; mean (SD), n; median [min, max]

19.4 (12.6), 19

16 [6, 58]

18.7 (8.4), 20

18 [6, 44]

19.1 (10.5), 39

18 [6, 58]

Age of mania onset; mean (SD), n; median [min, max]

21.1 (7.9), 15

20 [10, 35]

16.5 (5.7), 17

18 [6, 25]

18.7 (7.1), 32

18 [6, 35]

Bipolar I disorder; n (%)

19 (86)

18 (86)

37 (86)

Bipolar II disorder; n (%)

3 (14)

3 (14)

6 (14)

  1. aMinimum age set to 6 years